Stay updated on Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T04:44:12.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision was updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T23:25:52.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-11T11:11:53.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the revision tag from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T10:30:38.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Show glossary was added; capitalization tweaks in labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; and a new 'Revision: v3.4.0' note. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T06:23:53.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page shows an updated revision label, changing from v3.3.3 to v3.3.4. No study content, eligibility criteria, outcomes, or links are modified by this change. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:12:33.000Z thumbnail image

Stay in the know with updates to Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial page.